Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

BUY
$87.74 - $117.27 $87 - $117
1 Added 1.79%
57 $5,000
Q4 2022

Jan 31, 2023

SELL
$80.93 - $108.63 $1,375 - $1,846
-17 Reduced 23.29%
56 $5,000
Q3 2022

Oct 21, 2022

BUY
$82.16 - $96.94 $2,793 - $3,295
34 Added 87.18%
73 $6,000
Q2 2022

Aug 01, 2022

BUY
$71.48 - $86.85 $1,644 - $1,997
23 Added 143.75%
39 $3,000
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $297 - $370
4 Added 33.33%
16 $1,000
Q4 2021

Jan 28, 2022

BUY
$71.72 - $91.47 $860 - $1,097
12 New
12 $1,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Schubert & CO Portfolio

Follow Schubert & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

News

Stay updated on Schubert & CO with notifications on news.